Comparison of ultraviolet A light protection standards in the United States and European Union through in vitro measurements of commercially available sunscreens - 14/12/17
, Haoming Xu, BS a, Joseph W. Stanfield, MS b, Uli Osterwalder, MS c, Bernd Herzog, PhD dAbstract |
Background |
The importance of adequate ultraviolet A light (UVA) protection has become apparent in recent years. The United States and Europe have different standards for assessing UVA protection in sunscreen products.
Objective |
We sought to measure the in vitro critical wavelength (CW) and UVA protection factor (PF) of commercially available US sunscreen products and see if they meet standards set by the United States and the European Union.
Methods |
Twenty sunscreen products with sun protection factors ranging from 15 to 100+ were analyzed. Two in vitro UVA protection tests were conducted in accordance with the 2011 US Food and Drug Administration final rule and the 2012 International Organization for Standardization method for sunscreen effectiveness testing.
Results |
The CW of the tested sunscreens ranged from 367 to 382 nm, and the UVA PF of the products ranged from 6.1 to 32. Nineteen of 20 sunscreens (95%) met the US requirement of CW >370 nm. Eleven of 20 sunscreens (55%) met the EU desired ratio of UVA PF/SPF > 1:3.
Limitations |
The study only evaluated a small number of sunscreen products.
Conclusion |
The majority of tested sunscreens offered adequate UVA protection according to US Food and Drug Administration guidelines for broad-spectrum status, but almost half of the sunscreens tested did not pass standards set in the European Union.
Le texte complet de cet article est disponible en PDF.Key words : critical wavelength, photoprotection, sunscreen, ultraviolet A, UVA protection, UVA protection factor
Plan
| Dr Wang and Mr Xu contributed equally to this article. |
|
| Funding sources: None. |
|
| Dr Wang served as a consultant for Neutrogena. Dr Stanfield is the president of Stanfield Skin Research LLC, and a consultant for CRL Suncare LLC. Mr Osterwalder is a full-time employee of DSM Nutritional Products Ltd. Dr Herzog is a full-time employee of BASF Grenzach GmbH. |
|
| No other conflicts of interest were declared. |
Vol 77 - N° 1
P. 42-47 - juillet 2017 Retour au numéro
Article précédent
- The impact of oral Polypodium leucotomos extract on ultraviolet B response: A human clinical study
- Indermeet Kohli, Rubina Shafi, Prescilia Isedeh, James L. Griffith, Mohammed S. Al-Jamal, Narumol Silpa-archa, Bradford Jackson, Mohammed Athar, Nikiforos Kollias, Craig A. Elmets, Henry W. Lim, Iltefat H. Hamzavi
- 25-Hydroxyvitamin-D3 serum modulation after use of sunbeds compliant with European Union standards: A randomized open observational controlled trial
- Benedikt Weber, Chantal C. Bachmann, Ralph Braun, Alison G. Abraham, Andreas L. Serra, Günther F.L. Hofbauer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?